
Loading, please wait...

Loading, please wait...

Splenic cysts represent an uncommon clinical pathology that often poses challenging therapeutic dilemmas. Historically, complete splenectomy served as the standard surgical treatment for large or symptomatic lesions. However, total removal eliminates crucial immunological and phagocytic defenses, which dramatically increases the lifetime risk of overwhelming post-splenectomy infection. Consequently, modern surgical paradigms strongly prioritize organ-sparing techniques. Performing a laparoscopic partial splenectomy provides definitive cyst eradication while preserving functional splenic parenchyma. Nevertheless, splenic resection carries a persistent risk of substantial parenchymal hemorrhage. To address this technical hurdle, an innovative multidisciplinary approach combines preoperative super-selective distal splenic artery embolization with minimally invasive resection.
True splenic cysts contain an epithelial lining and typically arise from congenital developmental anomalies. In contrast, pseudocysts lack an inner cellular lining and usually develop secondary to blunt abdominal trauma, pancreatitis, or prior splenic infarction. When these benign lesions enlarge beyond five centimeters, patients frequently present with dull left upper quadrant abdominal discomfort, early satiety, or palpable splenomegaly. Additionally, expanding cysts introduce substantial risks of spontaneous rupture, secondary infection, and internal intracystic hemorrhage.
Diagnostic evaluation relies primarily on contrast-enhanced computed tomography or magnetic resonance imaging. These imaging modalities characterize the cyst diameter, wall thickness, and precise anatomical relationship with the splenic hilum. Segmental splenic arterial vascular anatomy follows an end-arterial distribution without extensive collateral communication between poles. Therefore, selective occlusion of specific segmental branches directly induces localized parenchymal ischemia. Surgeons must accurately map this vascular architecture before undertaking organ-sparing interventions. Complete anatomical visualization ensures that clinicians can formulate targeted resection plans that protect the healthy lower or upper pole parenchyma.
The spleen functions as the largest lymphoid reservoir in the human body, filtering encapsulated bacteria and regulating systemic immune responses. Complete asplenia exposes patients to overwhelming post-splenectomy infection, a life-threatening complication characterized by rapid-onset sepsis and high mortality. Furthermore, asplenic individuals exhibit elevated long-term risks of vascular thrombosis, pulmonary hypertension, and immune dysregulation. Maintaining at least twenty-five percent of well-vascularized splenic tissue generally preserves adequate immunological protection and prevents these dangerous hematologic sequelae.
Young and active individuals derive immense benefits from spleen preservation. For instance, maintaining splenic integrity allows adolescent and collegiate athletes to avoid lifetime antibiotic prophylaxis and complex revaccination regimens. Moreover, preserving native anatomy eliminates psychological distress regarding severe bacteremia. Spleen-preserving strategies include partial cyst decapsulation, marsupialization, cyst unroofing, and formal partial resection. Unfortunately, simple fenestration or unroofing carries high recurrence rates exceeding twenty percent because secretory epithelial cells remain intact. Conversely, partial surgical resection completely removes the cyst wall, which guarantees definitive cure. Therefore, parenchymal preservation through partial resection represents the optimal balance between functional preservation and permanent cyst eradication.
Intraoperative bleeding remains the most daunting technical obstacle during partial splenic resection. The fragile, highly vascularized splenic pulp bleeds profusely upon incisional disruption, frequently forcing unplanned conversions to total splenectomy. To overcome this limitation, interventional radiologists perform super-selective distal splenic artery embolization shortly before surgery. By cannulating distal segmental branches supplying the affected pole, clinicians deploy microcoils or vascular plugs to arrest regional arterial inflow.
This pre-resection vascular interruption generates multiple significant physiological advantages. First, selective ischemia substantially diminishes intraoperative blood loss during subsequent parenchymal division. Second, the ischemic demarcation line produces a vivid color distinction on the splenic capsule. Laparoscopic visualization instantly reveals the boundary between the pale devascularized diseased tissue and the pink, well-perfused residual parenchyma. Furthermore, distal embolization leaves the main splenic trunk and uninvolved segmental branches completely patent. Consequently, normal blood flow continues to nourish the healthy parenchyma, which prevents diffuse splenic infarction or subsequent abscess formation. By performing the endovascular procedure within twenty-four hours before resection, clinicians successfully minimize systemic post-embolization symptoms while maximizing operative visualization.
During laparoscopic partial splenectomy, precise patient positioning and meticulous port placement guarantee adequate exposure of the left upper quadrant. Surgeons place the patient in a modified right lateral decubitus position, allowing the splenic flexure of the colon and stomach to gravitate medially. After establishing pneumoperitoneum, laparoscopic shears divide the gastrocolic and splenocolic ligaments to access the lesser sac. Careful dissection exposes the splenic hilum, where surgeons confirm the absence of collateral flow to the target pole.
Because preoperative embolization creates a distinct ischemic boundary, surgeons identify the exact transection plane with absolute confidence. Energy devices, such as ultrasonic shears or advanced bipolar sealers, divide the splenic capsule and superficial parenchyma. Subsequently, clinicians deploy endoscopic staplers with vascular loads across deeper parenchymal tissue and intersegmental vascular structures. Alternatively, bipolar radiofrequency devices or water-cooled electrosurgical instruments achieve controlled hemostatic transection. Throughout the parenchymal division, the surgical team continuously monitors the residual pole for vibrant perfusion. Hemostatic matrices, fibrin sealants, or oxidized cellulose can reinforce the raw parenchymal edge. Ultimately, the resected specimen undergoes retrieval in an impermeable endobag, avoiding cyst rupture and intraperitoneal spillage.
The combination of super-selective embolization and laparoscopic partial splenectomy produces outstanding perioperative outcomes in published clinical series. Operative blood loss remains remarkably modest, often totaling under one hundred and fifty milliliters. Consequently, patients rarely require allogeneic blood transfusions, which significantly diminishes perioperative morbidity. Postoperative recovery proceeds rapidly without significant pain or systemic inflammatory distress. Most individuals tolerate normal oral intake within twenty-four to forty-eight hours and achieve prompt hospital discharge.
Long-term follow-up demonstrates excellent anatomical and physiological stability. Surveillance ultrasound or contrast-enhanced abdominal imaging confirms robust perfusion within the preserved remnant and verifies the complete absence of cyst recurrence. Furthermore, laboratory monitoring demonstrates normal platelet counts and intact phagocytic immune function without Howell-Jolly bodies on peripheral blood smears. Because the remaining spleen retains stable vascular inflow, patients achieve full tissue healing within eight to twelve weeks. Consequently, young individuals can safely resume intense physical training and high-impact contact sports without heightened vulnerability to splenic rupture. This combined multidisciplinary approach delivers a durable curative solution while maintaining lifetime host defense.
Preserving native splenic parenchyma maintains vital immunological and phagocytic defenses against encapsulated bacteria like Streptococcus pneumoniae. Total splenectomy exposes patients to lifelong risks of overwhelming post-splenectomy infection, which carries significant mortality. Furthermore, asplenia increases the incidence of systemic thromboembolism and pulmonary hypertension. Preserving at least twenty-five percent of healthy splenic tissue provides sufficient reticuloendothelial function to avert these lethal systemic complications and eliminates the need for lifelong antibiotic prophylaxis.
Super-selective distal embolization occludes targeted segmental branches directly feeding the affected pole, markedly reducing arterial pressure and intraoperative hemorrhage. Additionally, regional ischemia creates an unmistakable visual demarcation boundary between nonviable and perfused tissue. This clear anatomical landmark guides precise laparoscopic parenchymal transection without injuring main hilar vessels. Consequently, surgeons achieve definitive cyst resection with minimal blood loss, protecting the healthy remnant spleen and preventing emergency open conversion.
Athletic clearance requires complete surgical wound healing and objective confirmation of remnant splenic viability without subcapsular hematoma. Postoperative cross-sectional imaging, performed at two to three months, evaluates tissue perfusion and verifies structural stability. Furthermore, clinicians assess patient recovery, ensuring the complete resolution of abdominal tenderness and restoration of core muscular strength. Once imaging confirms adequate healing and stable residual splenic volume, active young individuals may safely return to full-contact athletic activities.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Healthcare professionals must exercise independent clinical judgment. Refer to the latest local and national guidelines for clinical practice.
References
1. Tay THZ et al. Super-selective distal splenic artery embolization-assisted laparoscopic partial splenectomy for a benign splenic cyst: a case report. J Minim Invasive Surg. 2026 Sep 15. doi: 10.7602/jmis.2026.29.3.172. PMID: 42745707.
2. Rossetti G, et al. Laparoscopic partial splenectomy for a splenic cyst. Ann Laparosc Endosc Surg. 2020;5:38. doi: 10.21037/ales-19-257.
3. Wang L, et al. How to Preserve the Spleen: Laparoscopic Partial Splenectomy as a Treatment for Splenic Hemangioma. J Vis Exp. 2026;(206):e69433. doi: 10.3791/69433.
4. Kaiser GM, et al. The laparoscopic spleen-preserving approach to splenic cysts: advantages and limitations. Zentralbl Chir. 2008;133(2):138-142. doi: 10.1055/s-2008-1004767.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Selective distal splenic artery embolization before laparoscopic partial splenectomy enables precise devascularization, reducing hemorrhage while preserving essential splenic tissue in benign splenic cyst resection.
Today

A multicenter study reveals that a significant proportion of HCV antibody-positive ophthalmic surgical patients remain untreated and eligible for direct-acting antivirals. Stratifying antibody titers and streamlining referral pathways can optimize hepatitis C micro-elimination efforts.
Today

The Delhi Cabinet has approved a key policy revision doubling the fixed monthly allowance for accredited social health activists. This financial enhancement bolsters grassroots maternal and child healthcare delivery, strengthens urban public health surveillance, and improves frontline community health worker retention.
Today

A multicenter REAL-LEAD registry sub-analysis evaluates how intravascular ultrasound-defined circumferential calcification and post-procedural minimum lumen area govern 1-year primary patency after drug-coated balloon angioplasty for femoropopliteal lesions.
Today

A systematic review and meta-analysis of 21 RCTs reveals that platelet-rich plasma provides small but statistically superior pain relief and functional improvements compared to hyaluronic acid at 12 months in knee osteoarthritis, influenced by platelet concentration and leukocyte enrichment.
Today

A multicenter real-world prospective study in Taiwan demonstrates that liraglutide effectively reduces body weight and BMI standard deviation score in adolescents with obesity. The therapy shows a favorable safety profile with mild gastrointestinal adverse events and zero treatment discontinuations due to intolerance.
Today